Vanguard Group’s Inhibikase Therapeutics IKT Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $6.29M | Buy |
|
|||||
2025
Q1 | $6.24M | Buy |
|
|||||
2024
Q4 | $9.23M | Buy |
|
|||||
2024
Q3 | $21.7K | Hold |
|
|||||
2024
Q2 | $20.2K | Hold |
|
|||||
2024
Q1 | $36.1K | Sell |
|
|||||
2023
Q4 | $104K | Sell |
|
|||||
2023
Q3 | $122K | Sell |
|
|||||
2023
Q2 | $319K | Sell |
|
|||||
2023
Q1 | $349K | Hold |
|
|||||
2022
Q4 | $265K | Buy |
|
|||||
2022
Q3 | $482K | Hold |
|
|||||
2022
Q2 | $394K | Hold |
|
|||||
2022
Q1 | $785K | Buy |
|
|||||
2021
Q4 | $704K | Hold |
|
|||||
2021
Q3 | $909K | Buy |
|
|||||
2021
Q2 | $1.32M | Buy |
|